Title: Oxytocin facilitation of social cognition skills training.

**Abstract**

Oxytocin (OT) can enhance the salience of social information. We evaluated whether this property of OT would enhance learning during social cognitive skills training exercises in individuals with schizophrenia. Subjects were 27 male schizophrenia outpatients who met DSM-IV-TR criteria for schizophrenia and were taking antipsychotic medications. We also evaluated potential indicators of OT effects in brain.

Methods: Subjects participated in a 6-week (12-session) course of Social Cognitive Skills Training (SCST) that focused on 3 areas: 1. Facial Affect Recognition; 2. Recognizing non-verbal gestures and vocal cues; 3. Empathy. Subjects were randomly assigned to receive either intranasal OT (40 IU) or placebo 30 minutes prior to each session. Hence, each session included both patients taking OT and placebo. We evaluated scores on social cognition measures; clinical symptoms; and neurocognition (MATRICS Consensus Cognitive Battery (MCCB)). Participants only received OT immediately prior to each training session; they did not receive OT between sessions or on the day of assessments. In a separate study we evaluated two potential biomarkers indicating OT's target engagement in brain: pupillary response to a facial identification task and EEG mu suppression during a biological motion task. For these studies patients received single intranasal doses of OT or placebo in randomized order one week apart.

Results: 13 patients were randomized to receive OT and 14 to placebo, and there were no significant demographic differences between the groups. On the social cognitive tests, subjects receiving OT demonstrated significantly greater improvements on the Empathic Accuracy Test than those receiving placebo (p=.03, d=.92 post-treatment and p=.03, d=.98 at 1 month follow-up). There were no OT-related effects for the other tests but there was a main effect of time on the Eckman Facial Recognition Test (p\<.0001 post-treatment and p\<.0001 at 1 month follow-up). There were no significant changes in clinical symptoms and cognition though a main effect of time for the MCCB neurocognitive composite score indicated improvement across both groups (p\<.01 at 1-month follow-up). In addition, there was a significant increase in left-hemisphere N170 amplitude for emotion identification in participants who received OT (p\<.05 at 1 month follow-up), but not in those receiving placebo.

Discussion: This study demonstrates possible therapeutic benefits of administering OT prior to training sessions that target social cognition. The effects of OT were most pronounced for empathic accuracy, a high-level social cognitive process, which has been shown to be more difficult to modify with current social cognition remediation programs. The benefits of OT can be attributed to enhancement of learning from training sessions rather than acute effects on testing ability since all assessments were scheduled at least 1 week apart from treatment administration. We also found that mu suppression was greater on OT than placebo and that OT reduced pupillary dilation to fearful faces. These findings indicate that OT is engaging areas of the brain associated with the processing of social information.
